Q1 China Preview: Digital Health, Volume Pricing Loom Large For J&J, Sanofi
Post-Coronavirus Trends To Watch
Executive Summary
While many pharma firms rush to develop treatments or vaccines for the pandemic, some are quietly betting on digital health tools to bolster their business in post-coronavirus China.